Overview


According to FutureWise analysis, the market for Acetaminophen API is estimated to be US$ 1.19 billion in 2023 and is expected to reach US$ 1.58 billion by 2031 at a CAGR of 3.6% over the forecast period of 2023-2031.

The Active Pharmaceutical Ingredient (API) is the bioactive substance within a drug product (such as a tablet, capsule, cream, or injectable) that induces the desired therapeutic effects. Acetaminophen is a widely used medication for its effectiveness in alleviating mild to moderate pain stemming from various sources like headaches, muscle aches, menstrual discomfort, colds, sore throats, toothaches, backaches, and even reactions to vaccinations. It also serves as a fever reducer. Additionally, Acetaminophen proves beneficial in managing pain associated with osteoarthritis, a form of arthritis arising from joint lining breakdown. It is classified as an analgesic (pain reliever) and antipyretic (fever reducer). It alters pain perception and promotes a cooling effect within the body. It is available in various forms, such as chewable tablets, capsules, oral suspensions, extended-release tablets, and injectables

For paediatric use, it is administered as instructed by the physician or if taken without prescription, can be given as the instructions mentioned to avoid any side effects. It is crucial to prevent administering adult formulations to children, as they may contain excessive amounts of Acetaminophen for younger individuals. Dosage should be determined based on the child's weight or age, as a healthcare professional advises. Proper storage and disposal measures should also be followed to prevent unintended ingestion and maintain medication efficacy.

FutureWise Market Research has published a report that provides an insightful analysis of Acetaminophen API Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts’ projects that Acetaminophen API Market will experience a significant growth.

According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • BOC Sciences
  • Tianjin Bofa Acetaminophen
  • Mallinckrodt plc
  • Kemcolour International
  • Changshu Huagang Acetaminophen
  • Haohua Industry
  • Kangle Acetaminophen
  • Angene International Limited
  • Anhui BBCA Acetaminophen
  • Granules India
  • Hebei Jiheng Acetaminophen
  • Glosel India Impex Pvt Ltd.
  • Flare S.A.
  • Silverline chemicals ltd
  • Emkay Pharma Pvt Ltd
  • Atabay K.S.V.T.
  • Anqiu Lu'An
  • United Pharma Industries Co Ltd
  • Liaoyuan City Baikang

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent Development in Acetaminophen API Market:

  • In April 2022, Genexa made a significant stride by introducing the first-ever clean Acetaminophen pain relief products tailored for adults. Genexa's Acetaminophen Extra Strength and Acetaminophen PM caplets boast identical active ingredients and dosages as the leading products in the category yet stand out for their exclusion of artificial dyes, synthetic fillers, and other preservatives.
  • In August 2021, Marksans Pharma achieved a notable milestone with the approval of their Acetaminophen ER Tablets by the United States FDA. This endorsement underscores Marksans' proficiency in formulating and delivering products using advanced extended-release tablet technology, setting a high standard in the pharmaceutical industry.

Several factors drive this market; one major factor is Acetaminophen is a widely used pain reliever, which is well-known for its efficacy and relatively low side effects, and thus, its demand for pain management is rising day by day. Hence, it is essential that this drug is available in medical stores and can be taken without any prescription, making it readily available and accessible to consumers. This accessibility is contributing to the high demand for Acetaminophen in the market. The surge in the prevalence of chronic diseases, which require pain relievers, is also a factor in driving market growth. It is the preferred drug for pain relief in paediatrics due to its fewer side effects and safety for the child.
Along with this, it is the safest drug that can be given to pregnant women, bolstering the market growth. The growing geriatric population requires certain pain relievers due to some chronic pain, and here comes Acetaminophen, which is the drug taken as a priority. Thus, considering all these factors, the market is fuelling at a high range and is increasing the revenue of the market.

However, with these drivers, there are significant restraints that are affecting the market growth as well. Similar to other medications, Acetaminophen also shows specific side effects. If taken in excess amounts or misused, it can lead to liver damage, which is a significant concern for the healthcare provider and patients. The generic versions of these drugs are available at lower prices, which can lead to price competition and impact the market's revenue growth. Some individuals may exhibit allergic reactions or sensitivities to these drugs, which can hamper the market growth.

By Dosage Form

  • Tablets
  • Oral Solution
  • Suppository
  • Injection
  • Others Dosage Forms

By Application

  • Medical Use
  • Veterinary Use

By End-Use

  • Pharmaceutical Companies
  • Research Laboratories
  • Academic Institutes
  • Contract Manufacturing Organizations (CMOs)/ Contract Research Organizations (CROs)

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process. 

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America holds the largest share of the market due to the well-established health infrastructure, early adoption of technological advancements, high healthcare expenditure, rising healthcare spending, and the availability of affordable drugs in this region. In addition, government initiatives are playing a significant role in raising funds and promoting advanced interventions in this medication, which are propelling the market growth.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the of Acetaminophen API Market By Dosage Form, By Application, By End User and By Region.
  • To cater comprehensive insights on factors such as drivers, restraints, trends, opportunity, and additionally segmental and regional factors impacting market growth.
  • To evaluate current market trends and forecast micro-markets and the overall market projections which are represents in format of data-sets and ppt.
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. 
  • To provide information on competitors which includes landscape mapping, technological advancements, R&D spending, news concerning strategic alliances, and new product launches
     

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

 

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Acetaminophen API Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Acetaminophen API Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Acetaminophen API Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Acetaminophen API Market, By Dosage Form Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Tablets
        2. Oral Solution
        3. Suppository
        4. Injection
        5. Other Dosage Forms

  • 8.   Acetaminophen API Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Medical Use
        2. Veterinary Use

  • 9.   Acetaminophen API Market, By End-Use Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Pharmaceutical Companies
        2. Research Laboratories
        3. Academic Institutes
        4. Contract Manufacturing Organizations (CMOs)/ Contract Research Organizations (CROs)

  • 10.   North America Acetaminophen API Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Acetaminophen API Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Acetaminophen API Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Acetaminophen API Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Acetaminophen API Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. BOC Sciences
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Tianjin Bofa Acetaminophen
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Mallinckrodt plc
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Kemcolour International
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Changshu Huagang Acetaminophen
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Haohua Industry
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Kangle Acetaminophen
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Angene International Limited
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Anhui BBCA Acetaminophen
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Granules India
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Hebei Jiheng Acetaminophen
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Glosel India Impex Pvt Ltd.
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
           13. Flare S.A.
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. Silverline chemicals ltd
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15. Emkay Pharma Pvt Ltd
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview
        16. Atabay K.S.V.T.
         16.1. Company Overview
         16.2. Product Portfolio
         16.3. SWOT Analysis
         16.4. Financial Overview
         16.5. Strategic Overview
        17. Anqiu Lu'An
         17.1. Company Overview
         17.2. Product Portfolio
         17.3. SWOT Analysis
         17.4. Financial Overview
         17.5. Strategic Overview
        18. United Pharma Industries Co Ltd
         18.1. Company Overview
         18.2. Product Portfolio
         18.3. SWOT Analysis
         18.4. Financial Overview
         18.5. Strategic Overview
        19. Liaoyuan City Baikang
         19.1. Company Overview
         19.2. Product Portfolio
         19.3. SWOT Analysis
         19.4. Financial Overview
         19.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client

Related Market

Active Pharmaceutical Ingredient (API) Market

Read More

Insulin API Market

Read More
Partner

Our Clients